Search Results for "Glaucoma Moringa Clinical Study"

13:09 EDT 5th October 2015 | BioPortfolio

Matching Channels

Matching News

Global Moringa Meet 2015 Showcases Latest Advancement in Moringa Farming Operations Through Science and Technology, Industry Trends & Quality Standards

Jaipur, Rajasthan (PRWEB) July 20, 2015 The Advanced Biofuel Center (ABC) is delighted to announce the 3rd Global Moringa Meetâ€...

Dead Sea Moringa® Begins Crowdfunding for RIS3UP™ Product

(PRWEB) July 09, 2015 Dead Sea Moringa, a company that develops an all-natural premium nutritional supplement made from the moringa ...

Urologic oncology: Moringa oleifera leaf for chemotherapy-induced infertility

First Glaucoma Patients Treated in the Netherlands Using InnFocus MicroShunt®

MIAMI, July 13, 2015 /PRNewswire/ -- InnFocus, Inc. reports that the first 3 surgeries in the Netherlands to treat glaucoma using the InnFocus MicroShunt® glaucoma drainage implant have been...

ForSight VISION5's Clinical Data Demonstrating 6-Month IOP-Lowering from a Single Dose Presented at World Glaucoma Congress; Company Completes Enrollment of Phase 2 Dose-Ranging Study

MENLO PARK, Calif., June 11, 2015 /PRNewswire/ -- ForSight VISION5 recently met two key clinical milestones: completion of enrollment of 121 subjects in its Phase 2 dose-ranging study, and presen...

InnFocus Concludes $32.8 Million Financing

MIAMI, Sept. 30, 2015 /PRNewswire/ -- InnFocus, Inc. reports the conclusion of a $32.8 million Series C financing. The Company is developing the InnFocus MicroShunt® glaucoma drainage system...

Transcend Medical Announces Intent to File Premarket Approval Application With FDA for the CyPass(R) Glaucoma Micro-Stent

MENLO PARK, CA -- (Marketwired) -- 05/05/15 -- Transcend Medical, Inc. announced today its intent to file a premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for t...

InnFocus FDA Phase One Enrollment Reaches 75 Patient Filing Milestone

MIAMI, April 13, 2015 /PRNewswire/ -- InnFocus Inc. reports that treatments for its U.S. Food and Drug Administration (FDA) Phase One clinical trial of the InnFocus MicroShunt® glaucoma drai...

Matching PubMed Articles

Immunomodulatory activity of methanolic leaf extract of Moringa oleifera in Wistar albino rats.

Globally, Moringa oleifera is used by different communities to treat various ailments including modulation of the immune system though with limited scientific evidence.

Evaluation of the analgesic, anti-inflammatory, anti-oxidant, phytochemical and toxicological properties of the methanolic leaf extract of commercially processed Moringa oleifera in some laboratory animals.

Moringa oleifera Lam (Moringaceae) is a highly valued plant, distributed in many countries of the tropics and subtropics. It has an impressive range of medicinal uses with high nutritional value.

Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats.

Moringa stenopetala has been used in traditional health systems to treat diabetes mellitus. The aim of this study was to investigate the antidiabetic activity of aqueous ethanol and n-butanol fraction...

Cultivation, Genetic, Ethnopharmacology, Phytochemistry and Pharmacology of Moringa oleifera Leaves: An Overview.

Moringa oleifera is an interesting plant for its use in bioactive compounds. In this manuscript, we review studies concerning the cultivation and production of moringa along with genetic diversity amo...

Co-administration of adjuvants along with Moringa oleifera attenuates beryllium-induced oxidative stress and histopathological alterations in rats.

Moringa oleifera Lam. (Moringaceae) is a rich source of antioxidants. All parts of the plant are medicinally important and have been used as traditional medicine for a variety of human ailments in Ind...

Search Whole site using Google


Advertisement Advertisement